Midstar Pharmaceuticals Private Limited
About Midstar Pharmaceuticals Private Limited
Data last updated:
Midstar Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 28 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2015PTC271334. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Suresh Kumar Gordhan Bhai Viroja and Rushabh Suresh Viroja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.3 Lakh, a decline of 59% compared to the previous year. For the same year it recorded a net loss of ₹1.81 Lakh (net margin -42%) and EBITDA of -₹1.81 Lakh (EBITDA margin -42%). Revenue has grown at a compounded annual rate (CAGR) of 103% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No.16 Building No.6 Samruddhi Evergreen Village Sape Kalyan – Karjat Road Badl, Apur, Thane, Maharashtra, India – 421503
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Midstar Pharmaceuticals Private Limited
The main business activity of Midstar Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Midstar Pharmaceuticals Private Limited FY 2025 filings available
Midstar Pharmaceuticals Private Limited reported revenue of ₹4.3 Lakh (down 59% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Midstar Pharmaceuticals Private Limited
Revenue fell 59% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA fell 185% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Midstar Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.81 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.81 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Midstar Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -42% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -42% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Midstar Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Midstar Pharmaceuticals Private Limited
Midstar Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Gordhan Bhai Viroja | Director | 28 Dec 2015 | 10 Years 9 Months | Current |
| Rushabh Suresh Viroja | Director | 30 Jan 2021 | 5 Years 8 Months | Current |
Peer Comparison of Midstar Pharmaceuticals Private Limited
Midstar Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Decor Pharmaceuticals Private Limited | ₹4.34 Lakh (FY 2025) | •••• | •••• | -65.0% | •••• | Lucknow, Uttar Pradesh, India |
| Aerocon Pharmaceuticals (OPC) Private Limited | ₹4.34 Lakh (FY 2020) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Moonbio Pharmaceuticals Private Limited | ₹4.34 Lakh (FY 2017) | •••• | •••• | •••• | Dhanbad, Jharkhand, India | |
| Troyfer Pharmaceuticals Private Limited | ₹4.32 Lakh (FY 2021) | •••• | •••• | 15.0% | •••• | Rewa, Madhya Pradesh, India |
| Byblis Pharmaceuticals Private Limited | ₹4.31 Lakh (FY 2024) | •••• | •••• | 19.0% | •••• | New Delhi, Delhi, India |
| Midstar Pharmaceuticals Private Limited this company | ₹4.3 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Thane, Maharashtra, India |
| Celestis Pharmaceuticals Private Limited | ₹4.3 Lakh (FY 2024) | •••• | •••• | -31.0% | •••• | Ahmedabad, Gujarat, India |
| Swansaw Pharmaceuticals Private Limited | ₹4.29 Lakh (FY 2024) | •••• | •••• | •••• | Visakhapatnam, Andhra Pradesh, India | |
| Guyer Pharmaceuticals Private Limited | ₹4.29 Lakh (FY 2019) | •••• | •••• | -9.0% | •••• | Daltonganj, Jharkhand, India |
| Brizwell Pharmaceuticals Private Limited | ₹4.29 Lakh (FY 2024) | •••• | •••• | •••• | Secunderabad, Telangana, India | |
| True Pill Pharmaceuticals Private Limited | ₹4.28 Lakh (FY 2024) | •••• | •••• | 132.0% | •••• | Bulandshahar, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Midstar Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Midstar Pharmaceuticals Private Limited
Midstar Pharmaceuticals Private Limited is audited by NAVIN DEDHIA AND CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NAVIN DEDHIA AND CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Midstar Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Midstar Pharmaceuticals Private Limited
Midstar Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Midstar Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Midstar Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Midstar Pharmaceuticals Private Limited
Midstar Pharmaceuticals Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Rushabh Suresh Viroja ceased to be Additional Director on 21 Oct 2021.
Credit Ratings, Litigation & Regulatory Alerts for Midstar Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Midstar Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Midstar Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Midstar Pharmaceuticals Private Limited
Midstar Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Midstar Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Midstar Pharmaceuticals Private Limited
Midstar Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in wholesale, within the trading industry. It was incorporated on 28 December 2015 (11+ years old) and is registered under CIN U24233MH2015PTC271334.
Midstar Pharmaceuticals reported revenue of ₹4.3 Lakh for FY 2025 (down 59% YoY).
Midstar Pharmaceuticals has 2 current directors:
- Suresh Kumar Gordhan Bhai Viroja - Director
- Rushabh Suresh Viroja - Director
Midstar Pharmaceuticals reported a net loss of ₹1.81 Lakh (net margin -42%) and EBITDA of -₹1.81 Lakh (EBITDA margin -42%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Midstar Pharmaceuticals is 103% over three years and 8% over five years. In the latest year (FY 2025) revenue fell 59%. CAGR is the steady yearly rate that links the first and the last year.
No. Midstar Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Midstar Pharmaceuticals is U24233MH2015PTC271334. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Midstar Pharmaceuticals was incorporated on 28 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Midstar Pharmaceuticals by revenue are Decor Pharmaceuticals Private Limited, Aerocon Pharmaceuticals (OPC) Private Limited, Moonbio Pharmaceuticals Private Limited, Troyfer Pharmaceuticals Private Limited, Byblis Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Rushabh Suresh Viroja ceased to be Additional Director on 21 Oct 2021. Amitkumar Ramanand Bhatia ceased to be Director on 12 Feb 2021. Rushabh Suresh Viroja was appointed as Director on 30 Jan 2021. Midstar Pharmaceuticals has 6 board changes on record in total.
The registered office of Midstar Pharmaceuticals is at Shop No.16 Building No.6 Samruddhi Evergreen Village Sape Kalyan – Karjat Road Badl, Apur, Thane, Maharashtra, India – 421503.